We read with great interest Henderson and colleagues’ paper in your journal (2009; 29:165–169), which reported that aripiprazole reduced olanzapine-induced overweight/obesity and hyperlipidemia in a 10-week placebo-controlled double-blind crossover study. This and their previous studies, provide a new way for controlling olanzapine- and clozapine-induced weight gain/obesity using another atypical antipsychotic, even without reducing the original olanzapine and clozapine doses, which is important particularly for treatment of refractory schizophrenia patients. ....
History
Citation
Deng, C., Chen, J., Hu, C. & Huang, X. (2010). What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?. Journal of Clinical Psychopharmacology, 30 (4), 480-481.